Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

Astute Medical is dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. The Company's focus is on community and hospital-acquired acute conditions that require rapid diagnosis and risk assessment. The company's current areas of interest include abdominal pain, acute coronary syndromes, cerebrovascular injury, kidney injury and sepsis. Founded in 2007, the company is led by Christopher Hibberd and Paul McPherson, former members of the management at Biosite Incorporated, a leading diagnostics company acquired by Inverness Medical Innovations in 2007 for $1.7 billion. Hibberd served at Biosite for 10 years, most recently as Senior Vice President Corporate Development. Dr. McPherson was at Biosite for 14 years, most recently as Vice President Research and Development.

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Shanghai Bode Gene Development Co., Ltd., established on 1998-03-22, Business scope includes bioengineering,Technology transfer in the field of genetic engineering expertise,technology development,technical consulting,Technical services and manufacture of related reagents and equipment,Sales;Bioengineering and Genetic Engineering Products,electronics,Chemical Products(In addition to dangerous goods)import and export business. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

CollabNet provides cloud-based application lifecycle management solutions for increasing enterprise agility and governance. The company offers TeamForge, an enterprise agile platform that simplifies and streamlines user workflow as well as offers enhanced planning, visibility, and reporting for increasingly complex software development environments; CloudForge, a cloud-based platform for developers to code, connect, and deploy projects to the public or private clouds; ScrumWorks Pro, an agile planning platform to unleash team productivity; and Subversion Edge that simplifies subversion installation, automates upgrades, and manages instances. The company also provides Enterprise Git, a control, security, and compliance solution for enterprises; CollabNet. GitEye, an intuitive graphical Git client with integration for users to plan, track, code review, and build tools; and integrations to orchestrate users’ favorite tools. In addition, it offers training services such as agile and product training services; c...

Engages in discovery and development of peptides for treatment of CNS disorders and cancer

Shanghai Golden Medical Insurance Bioengineering Co., Ltd., established on 2001-07-16, The scope of business includes engaging in bioengineering,Healthy food,Technology development in the field of cell biotechnology,Technical Services,technical consulting,technology transfer,Market information consultation and investigation(Do not engage in social investigation,social research,poll,opinion poll),marketing planning,Enterprise Marketing Planning,account Serive,Expo Services,business inquiries,chemical reagent(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Pharmaceutical Intermediates(Eliminate drugs and dangerous goods),cosmetic,medical instruments(Only varieties that do not require a medical device license)Sales,food sales. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Shanghai Taco Biotechnology Co., Ltd., established on 2014-05-06, Business scope includes engaging in biotechnology,Technology development in the field of chemical technology,technology transfer,technical consulting,Technical Services,Experimental analysis instrument,Industrial automation control system equipment,Class I and Class II medical devices,Inspection and analysis instrumentation,Sales of mechanical and electrical products and accessories,translation service,illustration,animation production service,Special Design for Architectural Decoration Construction Engineering,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

S.Biomedics Co. Ltd. operates as a biotechnology company. It engages in the research and development of cell therapies for regenerative biomedicine. The company was founded in August 2003 and is headquartered in Seoul, South Korea.

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Mariel Therapeutics, Inc., part of Ember Therapeutics, Inc., is an American company located in New York, NY, that provides treatment for osteoarthritis and kidney fibrosis diseases. It was acquired by Ember Therapeutics, Inc. on March 12, 2015.

National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON.

Kaneka Corp. engages in the manufacture and sale of chemicals, synthetic resins, and plastics. It operates through the following segments: Material Solutions, Quality of Life Solutions, Health Care Solutions, Nutrition Solutions and Others. The Material Solutions segment covers biodegradable polymers, materials that support the development of social infrastructure and mobility which includes the weight reduction and fuel efficiency improvement. The Quality of Life Solutions segment handles energy saving needs such as housing and living infrastructure, and development of Internet of things (IoT) and artificial intelligence (AI). The Health Care Solutions segment offers solutions through the fusion of devices and medicines, and develops healthcare business based on biopharmaceuticals and regenerative and cellular medicines. The Nutrition Solutions segment provides materials and supplement solutions to food production support in livestock and fishery industries. The Others segment provides agency services for property and life insurance. The company was founded on September 1, 1949 and is headquartered in Osaka, Japan.

Toyobo Co., Ltd. engages in the manufacture, processing, and sale of specialty and functional products. It operates through the following segments: Films and Functional Materials, Mobility, Life and Environment, Life Science, Real Estate, and Others The Films and Functional Materials segment includes manufacturing and sales of packaging films, industrial films, industrial adhesives, and optical functional materials. The Mobility segment handles the manufacture and sale of engineering plastics and airbag fabrics. The Life and Environment segment covers the manufacture and sales of aqua membranes, functional filters, super fibers, non-woven fabrics, functional clothing, apparel products, clothing textiles, and clothing fibers, The Life Science segment manufactures and sells bio-products such as enzymes for diagnostic reagents, pharmaceuticals, medical membranes, and medical equipment, The Real Estate segment engages in the leasing and management of real estate. The Others segment includes building design and construction, and information processing and logistic services. The company was founded by Eiichi Shibusawa on May 3, 1882 and is headquartered in Osaka, Japan.